/wp-content/uploads/2024/08/scancell-holdings-notice-of-agm-2023.pdf#new_tab 2024-08-21T20:20:48+00:00 /wp-content/uploads/2024/08/26.09.16-new-frontiers-in-t-cell-activation-and-targeting.pdf#new_tab 2024-08-21T21:26:56+00:00 /wp-content/uploads/2024/08/hardman-report-15-february-2018.pdf#new_tab 2024-08-21T21:28:05+00:00 /wp-content/uploads/2024/08/240730-scancell-appointment-of-cmo-press-release_final.pdf#new_tab 2024-09-05T14:00:08+00:00 /wp-content/uploads/2024/08/240724-scancell-asco-clinical-advisory-meeting-press-release-final_clean.pdf#new_tab 2024-09-05T14:02:03+00:00 /wp-content/uploads/2024/08/240709-scancell-appointment-of-florian-reinaud_redmile-to-the-board.pdf#new_tab 2024-09-05T14:02:36+00:00 /wp-content/uploads/2024/08/scancell-extension-of-clns-2-july-2024-final.pdf#new_tab 2024-09-05T14:03:14+00:00 /wp-content/uploads/2024/08/sclp-block-listing-return-and-nomad-name-change.pdf#new_tab 2024-09-05T14:03:39+00:00 /wp-content/uploads/2024/08/240621-change-of-nominated-advisor.pdf#new_tab 2024-09-05T14:04:08+00:00 /wp-content/uploads/2024/08/120624-scancell-glymab-agreement-press-release-final.pdf#new_tab 2024-09-05T14:14:49+00:00 /wp-content/uploads/2024/08/240530-scancell-receives-mhra-approval-to-expand-modify-trial_final.pdf#new_tab 2024-09-05T14:15:12+00:00 /wp-content/uploads/2024/08/240508-asco-conference-pr-002.pdf#new_tab 2024-09-05T14:21:21+00:00 /wp-content/uploads/2024/08/240509-sath-scancell-conference-pr.pdf#new_tab 2024-09-05T14:22:22+00:00 /wp-content/uploads/2024/08/20240520-scancell-issue-of-share-options_may_2024.pdf#new_tab 2024-09-05T14:22:51+00:00 /wp-content/uploads/2024/08/240502-scancell-to-present-at-cimt-2024-annual-meeting-v2.pdf#new_tab 2024-09-05T14:23:08+00:00 /wp-content/uploads/2024/08/240408-scancell-immuno-oncology-summit-conference-pr-final.pdf#new_tab 2024-09-05T14:23:42+00:00 /wp-content/uploads/2024/08/240320-scancell-aacr-pr-v2-clean.pdf#new_tab 2024-09-05T14:24:15+00:00 /wp-content/uploads/2024/08/240326_scancell-iscib1plus-first-patient-dosed_final.pdf#new_tab 2024-09-05T14:24:37+00:00 /wp-content/uploads/2024/08/240205-scancell-sath-to-the-board-v5.pdf#new_tab 2024-09-05T14:24:58+00:00 /wp-content/uploads/2024/08/240311-scancell-conference-pr.pdf#new_tab 2024-09-05T14:25:19+00:00 /wp-content/uploads/2024/08/scancell-next-gen-immuno-oncology-conference-pr.pdf#new_tab 2024-09-05T14:26:24+00:00 /wp-content/uploads/2024/08/240219-scancell-change-of-auditor-final.pdf#new_tab 2024-09-05T14:26:46+00:00 /wp-content/uploads/2024/08/240131-scancell-directorate-change-final.pdf#new_tab 2024-09-05T14:27:00+00:00 /wp-content/uploads/2024/08/scancell-interim-results-31-october-2023.pdf#new_tab 2024-09-05T14:27:30+00:00 /wp-content/uploads/2024/08/240124-scancell-notice-of-interim-results.pdf#new_tab 2024-09-05T14:27:50+00:00 /wp-content/uploads/2024/08/scancell-mrha-approval_final-draft-clean.pdf#new_tab 2024-09-05T14:28:08+00:00 /wp-content/uploads/2024/08/231129-results-of-agm.pdf#new_tab 2024-09-05T14:28:43+00:00 /wp-content/uploads/2024/08/231127-update-on-scope-27-11-23-final.pdf#new_tab 2024-09-05T14:29:07+00:00 /wp-content/uploads/2024/08/for-review-231109-scancell-smr-conference-pr-updated.pdf#new_tab 2024-09-05T14:29:41+00:00 /wp-content/uploads/2024/08/231031-scancell-sitc-conference-.pdf#new_tab 2024-09-05T14:30:15+00:00 /wp-content/uploads/2024/08/231031-scancell-preliminary-results-to-30-april-2023.pdf#new_tab 2024-09-05T14:30:38+00:00 /wp-content/uploads/2024/08/231020-scancell-revised-date-_-final.pdf#new_tab 2024-09-05T14:30:53+00:00 /wp-content/uploads/2024/08/231013-scancell-cancer-vaccine-congress-pr.pdf#new_tab 2024-09-05T14:31:19+00:00 /wp-content/uploads/2024/08/sclp-block-listing-return-october-2023-final.pdf#new_tab 2024-09-05T14:31:40+00:00 /wp-content/uploads/2024/08/230910-scancell-revised-date-v2-002.pdf#new_tab 2024-09-05T14:31:56+00:00 /wp-content/uploads/2024/08/230928-scancell-notice-of-final-results-2023.pdf#new_tab 2024-09-05T14:32:09+00:00 /wp-content/uploads/2024/08/230919-scancell-scope-rns-vfinal.pdf#new_tab 2024-09-05T14:32:39+00:00 /wp-content/uploads/2024/08/230913-scancell-ici-conference-pr-final_updated.pdf#new_tab 2024-09-05T14:32:53+00:00 /wp-content/uploads/2024/08/230907-scancell-head-of-business-development-pr-final.pdf#new_tab 2024-09-05T14:33:07+00:00 /wp-content/uploads/2024/08/230829-scancell-cfo-pr-final.pdf#new_tab 2024-09-05T14:33:21+00:00 /wp-content/uploads/2024/08/230710_scancell-pipeline-strategy-and-business-update_final.pdf#new_tab 2024-09-05T14:35:05+00:00 /wp-content/uploads/2024/08/230602_scancell-to-present-modi-1-data-at-asco_final.pdf#new_tab 2024-09-05T14:35:37+00:00 /wp-content/uploads/2024/08/apr-23-rns-issue-of-share-options-to-non-executive-directors-002.pdf#new_tab 2024-09-05T14:35:49+00:00 /wp-content/uploads/2024/08/scancell-to-present-modi-1-data-at-the-american-association-for-cancer-research-annual-meeting-_final_180423-002.pdf#new_tab 2024-09-05T14:41:05+00:00 /wp-content/uploads/2024/08/block-listing-application-to-aim_5.4.23-v2.pdf#new_tab 2024-09-05T14:41:24+00:00 /wp-content/uploads/2024/08/scancell-_svb-statement_final_13.03.23.pdf#new_tab 2024-09-05T14:41:40+00:00 /wp-content/uploads/2024/08/modify-efficacy-data-final-20.02.23.pdf#new_tab 2024-09-05T14:42:00+00:00 /wp-content/uploads/2024/08/scancell-announces-positive-response-in-covidity-trial_final_13.02.23.pdf#new_tab 2024-09-05T14:42:31+00:00 /wp-content/uploads/2024/08/scancell-appoints-dr-jean-michel-cossery-as-non-executive-chairman-of-the-board-01.02.23-final.pdf#new_tab 2024-09-05T14:43:51+00:00 /wp-content/uploads/2024/08/interim-report-31-october-2022.pdf#new_tab 2024-09-05T14:44:10+00:00 /wp-content/uploads/2024/08/scancell-result-of-agm-21.11.22.pdf#new_tab 2024-09-05T14:44:24+00:00 /wp-content/uploads/2024/08/scancell-in-licenses-vaccitech-technology-to-advance-modi-2-towards-the-clinic-final-07.11.22.pdf#new_tab 2024-09-05T14:44:54+00:00 /wp-content/uploads/2024/08/scancell-first-patient-dosed-in-the-expansion-phase-of-the-monotherapy-arms-of-modify-final-31.10.22.pdf#new_tab 2024-09-05T14:45:41+00:00 /wp-content/uploads/2024/08/scancell-preliminary-results-for-year-ended-30-april-2022.pdf#new_tab 2024-09-05T14:46:05+00:00 /wp-content/uploads/2024/08/genmab-press-release-24-oct-22-final-g-2.pdf#new_tab 2024-09-05T14:46:38+00:00 /wp-content/uploads/2024/08/scancell-change-of-registered-office.pdf#new_tab 2024-09-05T14:46:54+00:00 /wp-content/uploads/2024/08/scancell-first-patient-dosed-in-cohort-2-of-the-modify-phase-1-clinical-trial-final-16.08.22docx.pdf#new_tab 2024-09-05T14:47:22+00:00 /wp-content/uploads/2024/08/scancell-to-produce-and-clinically-validate-t-cell-redirecting-bispecific-antibodies-final-230622.pdf#new_tab 2024-09-05T14:48:10+00:00 /wp-content/uploads/2024/08/phase-2-scope-trial-of-scib1-vaccine-in-metastatic-melanoma-patients-expanded-final-15.06.22.pdf#new_tab 2024-09-05T14:48:43+00:00 /wp-content/uploads/2024/08/update-on-modi-trial-final-11.04.22.pdf#new_tab 2024-09-05T14:49:29+00:00 /wp-content/uploads/2024/08/scancell-update-on-covidity-phase-1-clinical-trial-recruitment-in-south-africa-29.03.22-final.pdf#new_tab 2024-09-05T14:52:03+00:00 /wp-content/uploads/2024/08/scancell-update-on-anti-glycan-antibodies-final-17.03.22.pdf#new_tab 2024-09-05T14:52:23+00:00 /wp-content/uploads/2024/08/scancell-update-on-covidity-phase-1-clinical-trial-in-south-africa-.pdf#new_tab 2024-09-05T14:52:40+00:00 /wp-content/uploads/2024/08/230728-scancell-rns-modi-1-plus-cpi-expansion-cohorts_final-002.pdf#new_tab 2024-09-05T15:45:30+00:00 /wp-content/uploads/2024/08/scancell-rns-share-option-exercise-period-extension_1307.pdf#new_tab 2024-09-05T15:50:53+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/scancell-founder-says-the-company-is-ready-to-commercialise-novel-medicines-to-counteract-cancer/ 2024-09-09T13:03:21+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/scancell-attends-and-sponsors-the-annual-melanoma-patient-meeting/ 2024-09-09T13:03:57+00:00 /wp-content/uploads/2024/08/scancell-first-patient-dosed-in-modi-1-phase-1-clinical-trial-final-13.06.22.pdf#new_tab 2024-09-09T13:05:12+00:00 /wp-content/uploads/2024/08/scancell-interim-results-final-26.01.22.pdf#new_tab 2024-09-09T13:05:46+00:00 /wp-content/uploads/2024/08/scancell-holdings-annual-report-to-30-april-2023.pdf#new_tab 2024-10-03T15:34:48+00:00 /wp-content/uploads/2024/08/scancell-holdings-financial-statements-to-30-april-2022.pdf#new_tab 2024-10-03T15:34:54+00:00 /wp-content/uploads/2024/08/annual-report-to-30-april-2021signed.pdf#new_tab 2024-10-03T15:34:58+00:00 /wp-content/uploads/2024/08/scancell-holdings-annual-report-april-2020-2.pdf#new_tab 2024-10-03T15:49:13+00:00 /wp-content/uploads/2024/08/annual-report-30-april-2019.pdf#new_tab 2024-10-03T15:49:18+00:00 /wp-content/uploads/2024/08/scancell-holdings-accounts-30042018.pdf#new_tab 2024-10-03T15:49:25+00:00 /wp-content/uploads/2024/08/scancell-holdings-final-accounts-30-04-2017.pdf#new_tab 2024-10-03T15:49:34+00:00 /wp-content/uploads/2024/08/scancell-holdings-annual-report-30-april-2016-.pdf#new_tab 2024-10-03T15:49:40+00:00 /wp-content/uploads/2024/08/scancell-holdings-finalaccounts-30042015.pdf#new_tab 2024-10-03T15:49:49+00:00 /wp-content/uploads/2024/08/annual-report-30th-april-2014.pdf#new_tab 2024-10-03T15:49:53+00:00 /wp-content/uploads/2024/08/scancell-holdings-plc-accounts.pdf#new_tab 2024-10-03T15:49:58+00:00 /wp-content/uploads/2024/08/scancell-holdings-plc-30042012.pdf#new_tab 2024-10-03T15:50:02+00:00 /wp-content/uploads/2024/08/scancell-holdings-plc-annual-report-30-4-11.pdf#new_tab 2024-10-03T15:50:08+00:00 /wp-content/uploads/2024/08/scancell-holdings-plc-30042010.pdf#new_tab 2024-10-03T15:50:12+00:00 /wp-content/uploads/2024/08/scancell-holdings-plc-final-accounts-2009.pdf#new_tab 2024-10-03T15:50:15+00:00 /wp-content/uploads/2024/08/interim-report-31st-october-2023.pdf#new_tab 2024-10-03T15:50:37+00:00 /wp-content/uploads/2024/08/interim-report-31-october-2022-1.pdf#new_tab 2024-10-03T15:50:47+00:00 /wp-content/uploads/2024/08/notes-to-the-interim-financial-statements-to-31.10.21.pdf#new_tab 2024-10-03T15:50:51+00:00 /wp-content/uploads/2024/08/interim-report-31st-october-2020.pdf#new_tab 2024-10-03T15:50:57+00:00 /wp-content/uploads/2024/08/interim-report-31-october-2019-final.pdf#new_tab 2024-10-03T15:51:02+00:00 /wp-content/uploads/2024/08/sh-interim-report-31-oct-2018-.pdf#new_tab 2024-10-03T15:51:07+00:00 /wp-content/uploads/2024/08/sh-interim-results-31-oct-2017-final.pdf#new_tab 2024-10-03T15:51:13+00:00 /wp-content/uploads/2024/08/interim-results-final-31-january-2017.pdf#new_tab 2024-10-03T15:51:17+00:00 /wp-content/uploads/2024/08/2014-sh-interim-results-final.pdf#new_tab 2024-10-03T15:51:26+00:00 /wp-content/uploads/2024/08/sh-interim-results-final-pdf.pdf#new_tab 2024-10-03T15:51:31+00:00 /wp-content/uploads/2024/08/unaudited-interim-result-for-6-months-ending-31st-oct-12.pdf#new_tab 2024-10-03T15:51:35+00:00 /wp-content/uploads/2024/08/scancell-interims-30-jan-2012.pdf#new_tab 2024-10-03T15:51:40+00:00 /wp-content/uploads/2024/08/sclp-interims-final-october-2010.pdf#new_tab 2024-10-03T15:51:45+00:00 /wp-content/uploads/2024/08/scancell-interim-results-october-2009.pdf#new_tab 2024-10-03T15:51:52+00:00 /wp-content/uploads/2024/10/asco_scope-study-poster-2may24_final-draft-1.0.pdf 2024-10-16T10:19:45+00:00 /wp-content/uploads/2024/10/aacr-2024-scib1-.pdf 2024-10-16T10:28:46+00:00 /wp-content/uploads/2024/10/scope_abstract_august-23_smr.pdf 2024-10-16T10:28:50+00:00 /wp-content/uploads/2024/10/sitc_scope-study-poster_october-23_final.pdf 2024-10-16T10:28:57+00:00 /wp-content/uploads/2024/10/shah-et-al-2023.pdf 2024-10-16T10:29:01+00:00 /wp-content/uploads/2024/10/shah-et-al-2022.pdf 2024-10-16T10:29:09+00:00 /wp-content/uploads/2024/10/aacr_modify-study-poster_march-2023_final-corrected.pdf 2024-10-16T10:29:16+00:00 /wp-content/uploads/2024/10/brentville-et-al-2023.pdf 2024-10-16T10:29:20+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/annual-meeting-of-the-american-association-for-cancer-research-aacr-14-19-april-2023-in-orlando-florida-usa/ 2024-10-16T10:29:24+00:00 /wp-content/uploads/2024/10/immunology-2023-choudhury-immune-responses-to-citrullinated-and-homocitrullinated-peptides-in-healthy-donors-are-not.pdf#new_tab 2024-10-16T10:29:40+00:00 /wp-content/uploads/2024/10/citrullinated-alpha-enolase.pdf#new_tab 2024-10-16T10:29:46+00:00 /wp-content/uploads/2024/10/bip-sitc-2022-poster.pdf#new_tab 2024-10-16T10:29:51+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2024/10/cook-et-al-2022.pdf#new_tab 2024-10-16T10:29:55+00:00 /wp-content/uploads/2024/10/choudhury-et-al-2022-moditope.pdf#new_tab 2024-10-16T10:29:59+00:00 /wp-content/uploads/2024/10/glymab_worldadclondon_final_ms_mnv.pdf#new_tab 2024-10-16T10:30:23+00:00 /wp-content/uploads/2024/10/pegs2023_fin-003.pdf#new_tab 2024-10-16T10:30:29+00:00 /wp-content/uploads/2024/10/houvast-et-al-2021-avidimab.pdf#new_tab 2024-10-16T10:31:14+00:00 /wp-content/uploads/2024/10/houvast-et-al-2020-avidimab.pdf#new_tab 2024-10-16T10:31:20+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2024/10/pegs-avidimab-2022-poster.pdf#new_tab 2024-10-16T12:02:59+00:00 /wp-content/uploads/2024/11/notice-of-agm-2024.pdf#new_tab 2024-11-04T14:54:33+00:00 /wp-content/uploads/2024/11/scancell-annual-report-2024-signed-signed.pdf#new_tab 2024-11-08T10:56:21+00:00 /wp-content/uploads/2024/11/notice-of-annual-general-meeting-october-2024.pdf#new_tab 2024-11-08T10:56:58+00:00 /wp-content/uploads/2024/11/agm-october-2024.pdf#new_tab 2024-11-08T11:02:35+00:00 /wp-content/uploads/2024/11/221002-scancell-appointment-of-phil-lhuillier-as-ceo-press-release-clean.pdf#new_tab 2024-11-14T10:38:29+00:00 /wp-content/uploads/2024/11/scancell-preliminary-results-2024-23-sept.pdf#new_tab 2024-11-14T10:40:52+00:00 /wp-content/uploads/2024/11/2400809-scancell-pharmajet-license-agreement_press-release.pdf#new_tab 2024-11-14T10:41:28+00:00 /wp-content/uploads/2024/11/Results-of-AGM-25-October-2024.pdf#new_tab 2024-11-14T11:00:45+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2024/11/Update-on-SCOPE-trial-18.11.24.pdf#new_tab 2024-11-18T07:00:26+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/it-is-with-great-sadness-that-scancell-announces-the-death-of-former-chairman-john-chiplin/ 2024-11-17T20:10:56+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2025/01/23.01.25-Scancell_Notice-of-Interim-Results_Press-Release_FINAL_1.pdf#new_tab 2025-01-27T13:08:33+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2025/01/Modi-1_PressRelease_Jan2025_FINAL.pdf#new_tab 2025-01-27T14:30:05+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2024/12/Scancell-Genmab-Commercial-License-Agreement_Press-Release.pdf#new_tab 2025-01-27T15:53:35+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2024/11/Modi-2-Vaccine-Nov-24.pdf 2025-01-28T11:00:24+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2025/01/Scancell-Interim-Results-31-October-2024.pdf#new_tab 2025-01-30T07:00:09+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2025/01/Scancell-Interim-Results-31-October-2024.pdf 2025-01-30T10:33:55+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2025/01/SCLP-Lighthouse-250130.pdf#new_tab 2025-01-30T13:20:08+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2025/01/SCLP-Update-250113-1.pdf#new_tab 2025-01-30T14:20:35+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2025/01/SCLP-Lighthouse-241206-1.pdf#new_tab 2025-01-30T14:24:51+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2025/01/SCLP-Lighthouse-241204-1.pdf#new_tab 2025-01-30T14:30:27+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2025/01/Scancell-Corporate-deck-FY-25-Interims.pdf#new_tab 2025-01-30T14:47:43+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2025/02/250217-Scancell_AACR-IO-Conference-Presentation_Press-Release.pdf#new_tab 2025-02-17T11:30:33+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2025/02/200225-Scancell-Issue-of-Share-Options.pdf#new_tab 2025-02-20T07:00:05+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/euromabnet-6th-antibody-validation-workshop-and-12th-meeting-hamburg-22-24-september-2022/ 2025-03-10T13:33:18+00:00 /wp-content/uploads/2025/03/AACR-IO-2025-TCR-poster-Final.pdf#new_tab 2025-03-12T15:12:05+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/seventh-international-cancer-immunotherapy-conference-cicon23-milan-september-2023-2-2/ 2025-03-12T16:47:43+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/21st-association-for-cancer-immunotherapy-cimt-annual-meeting-mainz-may-2024_old-2/ 2025-03-12T17:07:53+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2025/04/250401-Scancell_AACR-2025_Press-Release_FINAL.pdf#new_tab 2025-04-01T07:49:20+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2025/04/250414-Scancell-CVLP_Press-Release_NEW-FINAL.pdf#new_tab 2025-04-14T08:04:22+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2025/05/Scancell-AACR-Poster.pdf#new_tab 2025-05-02T10:56:05+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2025/05/250521-Scancell_Director-Dealing.pdf#new_tab 2025-05-21T07:00:38+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2025/06/20250625-Scancell-SCOPE-study-update.pdf#new_tab 2025-06-25T06:15:31+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2025/07/SCLP-Lighthouse-250625.pdf#new_tab 2025-07-10T14:27:23+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2025/07/Share-Option-Exercise-16-July-2025.pdf#new_tab 2025-07-16T06:00:25+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2025/07/Scancell-iSCIB1-strongly-improved-outcomes-in-Late-Stage-Melanoma-SCOPE-study-results.pdf#new_tab 2025-07-22T11:06:28+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2025/07/SCLP-Lighthouse-250722-Final.pdf#new_tab 2025-07-22T15:25:46+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2025/08/SCLP-Update-250804.pdf#new_tab 2025-08-04T09:03:24+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2025/08/040825-Scancell_Director-Dealing.pdf#new_tab 2025-08-04T09:45:33+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2025/07/20250722-SCOPE-Data_Press-Release-PL.pdf#new_tab 2025-08-04T14:40:11+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2025/08/080825-Scancell_Director-Dealing.pdf#new_tab 2025-08-08T12:02:00+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2025/09/Scancell-Notice-of-Results-04.09.25.pdf#new_tab 2025-09-04T07:11:50+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2025/09/Scancell-Preliminary-Results-September-2025.pdf#new_tab 2025-09-11T06:00:22+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2025/09/SCLP-Lighthouse-250911.pdf#new_tab 2025-09-11T07:00:59+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2025/09/Scancell-Financial-Year-End-2025-Results.pdf#new_tab 2025-09-11T12:25:42+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2025/09/160925-Scancell_Director-Dealing.pdf#new_tab 2025-09-16T06:00:21+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2025/10/AGM-Notice-Announcement.pdf#new_tab 2025-10-03T06:08:52+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2025/10/Scancell-2025-AGM-Notice.pdf#new_tab 2025-10-03T06:08:02+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2025/10/20251030-Results-of-AGM.pdf#new_tab 2025-10-30T18:29:06+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2025/11/20251107-SITC-Presentation-Final.pdf#new_tab 2025-11-07T07:00:13+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2025/11/SCLP-Outlook-251117.pdf#new_tab 2025-11-17T09:22:00+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/qa-with-cmo-nermeen-varawalla/ 2025-11-28T10:43:56+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2024/10/Scancell-home-inset_Nermeen.png https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2025/12/20251209-SCOPE-data_final-PL-1.pdf#new_tab 2025-12-09T07:00:30+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2025/12/SCLP-Lighthouse-251209.pdf#new_tab 2025-12-09T09:14:52+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2025/12/ESMO-IO-Dec-2025-FINAL-27th-Nov-2025.pdf 2025-12-10T14:10:29+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2025/12/SCOPE-data-update-presentation-11-December-2025.pdf#new_tab 2025-12-12T08:35:06+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2026/01/Scancell-Notice-of-Results_-Interim-2025-1.pdf#new_tab 2026-01-22T09:24:12+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2026/01/FDA-clears-global-Phase-III-trial-for-iSCIB1-260126.pdf#new_tab 2026-01-26T09:03:00+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2026/01/20260126-iSCIB1-IND-clearance-Final.pdf#new_tab 2026-01-26T12:17:20+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2026/01/Scancell-Interim-Results-31-October-2025-Final.pdf 2026-01-29T07:18:41+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2026/01/Scancell-Interim-Results-31-October-2025-Final.pdf#new_tab 2026-01-29T07:25:42+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2025/09/Scancell-FY25-Annual-Report-Signed-signed.pdf#new_tab 2026-01-29T07:44:44+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2026/01/SCLP-Lighthouse-260129.pdf#new_tab 2026-01-29T09:41:23+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2026/01/Scancell-Interims-FY26-Presentation_FINAL2.pdf#new_tab 2026-01-29T14:08:24+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2026/03/Edison-Report-Redesigning-Immunity.pdf#new_tab 2026-03-05T16:15:08+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2026/04/Scancell-CFO-Transition-PR-FINAL-PL.pdf#new_tab 2026-04-02T06:00:21+00:00 https://infallible-montalcini.213-158-90-7.plesk.page/wp-content/uploads/2026/04/Scancell-Receives-FDA-Fast-Track-Designation-Press-Release.pdf#new_tab 2026-04-28T06:00:11+00:00